{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T18:50:49Z","timestamp":1775155849687,"version":"3.50.1"},"reference-count":66,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T00:00:00Z","timestamp":1539129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100001794","name":"Brain Tumor Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001794","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title\/>\n                  <jats:p>Brain tumors comprise 2% of all cancers but are disproportionately responsible for cancer-related deaths. The 5-year survival rate of glioblastoma, the most common form of malignant brain tumor, is only 4.7%, and the overall 5-year survival rate for any brain tumor is 34.4%. In light of the generally poor clinical outcomes associated with these malignancies, there has been interest in the concept of brain tumor screening through magnetic resonance imaging. Here, we will provide a general overview of the screening principles and brain tumor epidemiology, then highlight the major studies examining brain tumor prevalence in asymptomatic populations in order to assess the potential benefits and drawbacks of screening for brain tumors.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Implications for Practice<\/jats:title>\n                  <jats:p>Magnetic resonance imaging (MRI) screening in healthy asymptomatic adults can detect both early gliomas and other benign central nervous system abnormalities. Further research is needed to determine whether MRI will improve overall morbidity and mortality for the screened populations and make screening a worthwhile endeavor.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1634\/theoncologist.2018-0177","type":"journal-article","created":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T15:56:13Z","timestamp":1539186973000},"page":"375-384","source":"Crossref","is-referenced-by-count":38,"title":["Magnetic Resonance Imaging-Based Screening for Asymptomatic Brain Tumors: A Review"],"prefix":"10.1093","volume":"24","author":[{"given":"Alfred I.","family":"Neugut","sequence":"first","affiliation":[{"name":"Department of Medicine, Columbia University, New York, New York, USA"},{"name":"Department of Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, Columbia University, New York, New York, USA"},{"name":"Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Sackstein","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace C.","family":"Hillyer","sequence":"additional","affiliation":[{"name":"Department of Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, Columbia University, New York, New York, USA"},{"name":"Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith S.","family":"Jacobson","sequence":"additional","affiliation":[{"name":"Department of Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, Columbia University, New York, New York, USA"},{"name":"Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Bruce","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Columbia University, New York, New York, USA"},{"name":"Department of Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, Columbia University, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew B.","family":"Lassman","sequence":"additional","affiliation":[{"name":"Department of Neurology, Columbia University, New York, New York, USA"},{"name":"Department of Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, Columbia University, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip A.","family":"Stieg","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Weill-Cornell Medical College, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,10,10]]},"reference":[{"issue":"suppl 4","key":"2021122506323492600_onco12709-bib-0001","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/nov189","article-title":"CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2008-2012","volume":"17","author":"Ostrom","year":"2015","journal-title":"Neuro Oncol"},{"key":"2021122506323492600_onco12709-bib-0002","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4103\/0972-3919.106698","article-title":"Role of (18)F-fluorodeoxyglucose positron emission tomography scan in differentiating enhancing brain tumors","volume":"26","author":"Das","year":"2011","journal-title":"Indian J Nucl Med"},{"key":"2021122506323492600_onco12709-bib-0003","doi-asserted-by":"crossref","first-page":"e112577","DOI":"10.1371\/journal.pone.0112577","article-title":"Evaluation of the diagnostic performance of magnetic resonance spectroscopy in brain tumors: A systematic review and meta-analysis","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"2021122506323492600_onco12709-bib-0004","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1136\/ewjm.175.1.37","article-title":"Assessing diagnostic and screening tests: Part 2. How to use the research literature on diagnosis","volume":"175","author":"Gilbert","year":"2001","journal-title":"West J Med"},{"key":"2021122506323492600_onco12709-bib-0005","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1053\/j.seminoncol.2010.05.006","article-title":"Principles of cancer screening: Lessons from history and study design issues","volume":"37","author":"Croswell","year":"2010","journal-title":"Semin Oncol"},{"key":"2021122506323492600_onco12709-bib-0006","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0025-6196(11)60730-1","article-title":"Brain magnetic resonance imaging scans for asymptomatic patients: Role in medical screening","volume":"83","author":"Komotar","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"2021122506323492600_onco12709-bib-0007","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1093\/jnci\/95.12.868","article-title":"Lead times and overdetection due to prostate-specific antigen screening: Estimates from the European Randomized Study of Screening for Prostate Cancer","volume":"95","author":"Draisma","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"2021122506323492600_onco12709-bib-0008","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1158\/1055-9965.EPI-14-0275","article-title":"Epidemiologic and molecular prognostic review of glioblastoma","volume":"23","author":"Thakkar","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2021122506323492600_onco12709-bib-0009","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/neuonc\/nou087","article-title":"The epidemiology of glioma in adults: A \u201cstate of the science\u201d review","volume":"16","author":"Ostrom","year":"2014","journal-title":"Neuro Oncol"},{"key":"2021122506323492600_onco12709-bib-0010","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1215\/15228517-2007-016","article-title":"Incidence of gliomas by anatomic location","volume":"9","author":"Larjavaara","year":"2007","journal-title":"Neuro Oncol"},{"key":"2021122506323492600_onco12709-bib-0011","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000222090","article-title":"Descriptive epidemiology of cerebral gliomas in northwest Greece and study of potential predisposing factors, 2005-2007","volume":"33","author":"Gousias","year":"2009","journal-title":"Neuroepidemiology"},{"key":"2021122506323492600_onco12709-bib-0012","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s12254-012-0014-3","article-title":"Current treatment of low grade gliomas","volume":"5","author":"van den Bent","year":"2012","journal-title":"Memo"},{"key":"2021122506323492600_onco12709-bib-0013","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1227\/01.NEU.0000325729.41085.73","article-title":"Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas","volume":"63","author":"McGirt","year":"2008","journal-title":"Neurosurgery"},{"key":"2021122506323492600_onco12709-bib-0014","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1007\/s00701-009-0473-4","article-title":"Long-term outcome and survival of surgically treated supratentorial low-grade glioma in adult patients","volume":"151","author":"Ahmadi","year":"2009","journal-title":"Acta Neurochir (Wien)"},{"key":"2021122506323492600_onco12709-bib-0015","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nrneurol.2017.54","article-title":"Management of diffuse low-grade gliomas in adults - use of molecular diagnostics","volume":"13","author":"Buckner","year":"2017","journal-title":"Nat Rev Neurol"},{"key":"2021122506323492600_onco12709-bib-0016","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1001\/jama.2012.12807","article-title":"Comparison of a strategy favoring early surgical resection vs a strategy favoring watchful waiting in low-grade gliomas","volume":"308","author":"Jakola","year":"2012","journal-title":"JAMA"},{"key":"2021122506323492600_onco12709-bib-0017","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1093\/annonc\/mdx230","article-title":"Surgical resection versus watchful waiting in low-grade gliomas","volume":"28","author":"Jakola","year":"2017","journal-title":"Ann Oncol"},{"key":"2021122506323492600_onco12709-bib-0018","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1016\/S0959-8049(03)00603-8","article-title":"Cause of death and long-term survival in patients with neuro-epithelial brain tumours: A population-based study","volume":"39","author":"Johannesen","year":"2003","journal-title":"Eur J Cancer"},{"key":"2021122506323492600_onco12709-bib-0019","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1200\/JCO.2007.13.9337","article-title":"Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas","volume":"26","author":"Smith","year":"2008","journal-title":"J Clin Oncol"},{"key":"2021122506323492600_onco12709-bib-0020","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00701-011-1216-x","article-title":"Awake surgery for incidental WHO grade II gliomas involving eloquent areas","volume":"154","author":"Duffau","year":"2012","journal-title":"Acta Neurochir (Wien)"},{"key":"2021122506323492600_onco12709-bib-0021","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.3171\/2014.9.JNS141396","article-title":"Is there a risk of seizures in \u201cpreventive\u201d awake surgery for incidental diffuse low-grade gliomas?","volume":"122","author":"Lima","year":"2015","journal-title":"J Neurosurg"},{"key":"2021122506323492600_onco12709-bib-0022","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.neuchi.2016.08.007","article-title":"Surgical resection of incidental diffuse gliomas involving eloquent brain areas. Rationale, functional, epileptological and oncological outcomes","volume":"63","author":"Lima","year":"2017","journal-title":"Neurochirurgie"},{"key":"2021122506323492600_onco12709-bib-0023","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.2353\/ajpath.2007.070011","article-title":"Genetic pathways to primary and secondary glioblastoma","volume":"170","author":"Ohgaki","year":"2007","journal-title":"Am J Pathol"},{"key":"2021122506323492600_onco12709-bib-0024","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3171\/2011.9.JNS111068","article-title":"Natural history and surgical management of incidentally discovered low-grade gliomas","volume":"116","author":"Potts","year":"2012","journal-title":"J Neurosurg"},{"key":"2021122506323492600_onco12709-bib-0025","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/ana.22106","article-title":"Natural history of incidental World Health Organization grade II gliomas","volume":"68","author":"Pallud","year":"2010","journal-title":"Ann Neurol"},{"key":"2021122506323492600_onco12709-bib-0026","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11060-010-0386-3","article-title":"Epidemiology and etiology of meningioma","volume":"99","author":"Wiemels","year":"2010","journal-title":"J Neurooncol"},{"key":"2021122506323492600_onco12709-bib-0027","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3171\/jns.2006.105.4.538","article-title":"Brain Tumor Research G. Indications for surgery in patients with asymptomatic meningiomas based on an extensive experience","volume":"105","author":"Yano","year":"2006","journal-title":"J Neurosurg"},{"key":"2021122506323492600_onco12709-bib-0028","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.nec.2015.11.012","article-title":"Incidental meningiomas: Management in the neuroimaging era","volume":"27","author":"Spasic","year":"2016","journal-title":"Neurosurg Clin N Am"},{"key":"2021122506323492600_onco12709-bib-0029","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s10143-015-0619-1","article-title":"Clinical characteristics of patients with asymptomatic intracranial meningiomas and results of their surgical management","volume":"38","author":"Zeng","year":"2015","journal-title":"Neurosurg Rev"},{"key":"2021122506323492600_onco12709-bib-0030","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s00701-006-0909-z","article-title":"Morbidity in 201 patients with small sized meningioma treated by microsurgery","volume":"148","author":"Reinert","year":"2006","journal-title":"Acta Neurochir (Wien)"},{"key":"2021122506323492600_onco12709-bib-0031","doi-asserted-by":"crossref","first-page":"766","DOI":"10.3171\/jns.2000.92.5.0766","article-title":"Incidence and clinical features of asymptomatic meningiomas","volume":"92","author":"Kuratsu","year":"2000","journal-title":"J Neurosurg"},{"key":"2021122506323492600_onco12709-bib-0032","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.3171\/2010.3.JNS091966","article-title":"Treatment decision making based on the published natural history and growth rate of small meningiomas","volume":"113","author":"Sughrue","year":"2010","journal-title":"J Neurosurg"},{"key":"2021122506323492600_onco12709-bib-0033","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3171\/jns.1995.83.2.0222","article-title":"The natural history and growth rate of asymptomatic meningiomas: A review of 60 patients","volume":"83","author":"Olivero","year":"1995","journal-title":"J Neurosurg"},{"key":"2021122506323492600_onco12709-bib-0034","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1530\/eje.1.02107","article-title":"Subclinical adenomas in postmortem pituitaries: Classification and correlations to clinical data","volume":"154","author":"Buurman","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"2021122506323492600_onco12709-bib-0035","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1056\/NEJM198101153040306","article-title":"Microadenomas of the pituitary and abnormal sellar tomograms in an unselected autopsy series","volume":"304","author":"Burrow","year":"1981","journal-title":"N Engl J Med"},{"key":"2021122506323492600_onco12709-bib-0036","doi-asserted-by":"crossref","first-page":"817","DOI":"10.7326\/0003-4819-120-10-199405150-00001","article-title":"Pituitary magnetic resonance imaging in normal human volunteers: Occult adenomas in the general population","volume":"120","author":"Hall","year":"1994","journal-title":"Ann Intern Med"},{"key":"2021122506323492600_onco12709-bib-0037","first-page":"287","article-title":"Incidental pituitary macroadenoma: A population-based study","volume":"314","author":"Nammour","year":"1997","journal-title":"Am J Med Sci"},{"key":"2021122506323492600_onco12709-bib-0038","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1210\/jc.2010-1054","article-title":"Natural history of nonfunctioning pituitary adenomas and incidentalomas: A systematic review and metaanalysis","volume":"96","author":"Fernandez-Balsells","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122506323492600_onco12709-bib-0039","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0194-5998(99)70319-0","article-title":"Incidental discovery of acoustic neuromas","volume":"120","author":"Selesnick","year":"1999","journal-title":"Otolaryngol Head Neck Surg"},{"key":"2021122506323492600_onco12709-bib-0040","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0194-5998(00)70189-6","article-title":"Prevalence of unsuspected acoustic neuroma found by magnetic resonance imaging","volume":"122","author":"Anderson","year":"2000","journal-title":"Otolaryngol Head Neck Surg"},{"key":"2021122506323492600_onco12709-bib-0041","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archotol.131.3.241","article-title":"The prevalence of \u201cincidental\u201d acoustic neuroma","volume":"131","author":"Lin","year":"2005","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"2021122506323492600_onco12709-bib-0042","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF00464351","article-title":"The incidence of acoustic neuroma in autopsy material","volume":"240","author":"Karjalainen","year":"1984","journal-title":"Arch Otorhinolaryngol"},{"key":"2021122506323492600_onco12709-bib-0043","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1001\/archotol.1975.00780310013004","article-title":"Occult schwannomas of the vestibular nerve","volume":"101","author":"Stewart","year":"1975","journal-title":"Arch Otolaryngol"},{"key":"2021122506323492600_onco12709-bib-0044","volume-title":"Asymptomatic acoustic schwannoma","author":"Ohtani","year":"1997"},{"key":"2021122506323492600_onco12709-bib-0045","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/MAO.0b013e3181d279a3","article-title":"Acoustic neuroma growth: A systematic review of the evidence","volume":"31","author":"Nikolopoulos","year":"2010","journal-title":"Otol Neurotol"},{"key":"2021122506323492600_onco12709-bib-0046","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.3171\/2010.11.JNS10257","article-title":"Extent of resection and the long-term durability of vestibular schwannoma surgery","volume":"114","author":"Sughrue","year":"2011","journal-title":"J Neurosurg"},{"key":"2021122506323492600_onco12709-bib-0047","doi-asserted-by":"crossref","first-page":"662","DOI":"10.3171\/2007.5.16836","article-title":"Conservative management of 386 cases of unilateral vestibular schwannoma: Tumor growth and consequences for treatment","volume":"110","author":"Bakkouri","year":"2009","journal-title":"J Neurosurg"},{"key":"2021122506323492600_onco12709-bib-0048","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1258\/0022215054273089","article-title":"Conservative management of sporadic unilateral acoustic neuromas","volume":"119","author":"Flint","year":"2005","journal-title":"J Laryngol Otol"},{"key":"2021122506323492600_onco12709-bib-0049","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00005537-200004000-00002","article-title":"Natural history of acoustic neuromas","volume":"110","author":"Rosenberg","year":"2000","journal-title":"Laryngoscope"},{"key":"2021122506323492600_onco12709-bib-0050","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1001\/jama.282.1.36","article-title":"Incidental findings on brain magnetic resonance imaging from 1000 asymptomatic volunteers","volume":"282","author":"Katzman","year":"1999","journal-title":"JAMA"},{"key":"2021122506323492600_onco12709-bib-0051","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jns.2005.09.008","article-title":"Incidental findings in magnetic resonance imaging of the brains of healthy young men","volume":"240","author":"Weber","year":"2006","journal-title":"J Neurol Sci"},{"key":"2021122506323492600_onco12709-bib-0052","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1148\/radiol.2016160218","article-title":"Prevalence, clinical management, and natural course of incidental findings on brain MR images: The population-based Rotterdam scan study","volume":"281","author":"Bos","year":"2016","journal-title":"Radiology"},{"key":"2021122506323492600_onco12709-bib-0053","doi-asserted-by":"crossref","first-page":"e0151080","DOI":"10.1371\/journal.pone.0151080","article-title":"Incidental intracranial findings and their clinical impact; the HUNT MRI study in a general population of 1006 participants between 50-66 years","volume":"11","author":"Haberg","year":"2016","journal-title":"PLoS One"},{"key":"2021122506323492600_onco12709-bib-0054","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1056\/NEJMoa070972","article-title":"Incidental findings on brain MRI in the general population","volume":"357","author":"Vernooij","year":"2007","journal-title":"N Engl J Med"},{"key":"2021122506323492600_onco12709-bib-0055","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2176\/nmc.41.431","article-title":"Asymptomatic brain tumor detected at brain check-up","volume":"41","author":"Onizuka","year":"2001","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"2021122506323492600_onco12709-bib-0056","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1601-5215.2008.00273.x","article-title":"Incidental brain MRI abnormalities in 60- to 64-year-old community-dwelling individuals: Data from the Personality and Total Health Through Life study","volume":"20","author":"Kumar","year":"2008","journal-title":"Acta Neuropsychiatr"},{"key":"2021122506323492600_onco12709-bib-0057","doi-asserted-by":"crossref","first-page":"b3016","DOI":"10.1136\/bmj.b3016","article-title":"Incidental findings on brain magnetic resonance imaging: Systematic review and meta-analysis","volume":"339","author":"Morris","year":"2009","journal-title":"BMJ"},{"key":"2021122506323492600_onco12709-bib-0058","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1002\/cncr.28610","article-title":"Silent diffuse low-grade glioma: Toward screening and preventive treatment?","volume":"120","author":"Mandonnet","year":"2014","journal-title":"Cancer"},{"key":"2021122506323492600_onco12709-bib-0059","doi-asserted-by":"crossref","first-page":"96","DOI":"10.4103\/2152-7806.74243","article-title":"Gliomas: Survival, origin and early detection","volume":"1","author":"Kelly","year":"2010","journal-title":"Surg Neurol Int"},{"key":"2021122506323492600_onco12709-bib-0060","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s00701-016-2769-5","article-title":"MRI screening for glioma: A preliminary survey of healthy potential candidates","volume":"158","author":"Mandonnet","year":"2016","journal-title":"Acta Neurochir (Wien)"},{"key":"2021122506323492600_onco12709-bib-0061","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s11060-017-2443-7","article-title":"Patterns of care and outcomes of multi-agent versus single-agent chemotherapy as part of multimodal management of low grade glioma","volume":"133","author":"Haque","year":"2017","journal-title":"J Neurooncol"},{"key":"2021122506323492600_onco12709-bib-0062","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1136\/practneurol-2017-001604","article-title":"Contemporary management of low-grade glioma: A paradigm shift in neuro-oncology","volume":"17","author":"Hayhurst","year":"2017","journal-title":"Pract Neurol"},{"key":"2021122506323492600_onco12709-bib-0063","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s12094-017-1631-4","article-title":"Diffuse low-grade glioma: A review on the new molecular classification, natural history and current management strategies","volume":"19","author":"Delgado-L\u00f3pez","year":"2017","journal-title":"Clin Transl Oncol"},{"key":"2021122506323492600_onco12709-bib-0064","doi-asserted-by":"crossref","first-page":"e841","DOI":"10.1016\/j.wneu.2014.08.052","article-title":"Screening for brain cancer: Why (not)","volume":"82","author":"Alves","year":"2014","journal-title":"World Neurosurg"},{"key":"2021122506323492600_onco12709-bib-0065","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jpeds.2015.07.001","article-title":"The use of magnetic resonance imaging screening for optic pathway gliomas in children with neurofibromatosis type 1","volume":"167","author":"Prada","year":"2015","journal-title":"J Pediatr"},{"key":"2021122506323492600_onco12709-bib-0066","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/ajmg.a.20650","article-title":"Outcomes of systematic screening for optic pathway tumors in children with neurofibromatosis type 1","volume":"127A","author":"Blazo","year":"2004","journal-title":"Am J Med Genet A"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1634\/theoncologist.2018-0177","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1634\/theoncologist.2018-0177","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/24\/3\/375\/41916848\/oncolo_24_3_375.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/24\/3\/375\/41916848\/oncolo_24_3_375.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,25]],"date-time":"2021-12-25T06:33:24Z","timestamp":1640414004000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/24\/3\/375\/6439119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,10]]},"references-count":66,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,10,10]]},"published-print":{"date-parts":[[2019,3,1]]}},"URL":"https:\/\/doi.org\/10.1634\/theoncologist.2018-0177","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,3,1]]},"published":{"date-parts":[[2018,10,10]]}}}